Shane Olwill
Corporate Officer/Principal at PIERIS PHARMACEUTICALS, INC.
Net worth: 849 $ as of 2024-03-30
Profile
Shane Olwill is currently the Chief Development Officer & Senior Vice President at Pieris Pharmaceuticals, Inc. He previously worked as the Director of Research at Fusion Antibodies Plc.
Dr. Olwill holds a doctorate degree from the University of Ulster.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-02-23 | 4,638 ( 0.00% ) | 849 $ | 2024-03-30 |
Shane Olwill active positions
| Companies | Position | Start |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Former positions of Shane Olwill
| Companies | Position | End |
|---|---|---|
| FUSION ANTIBODIES PLC | Chief Tech/Sci/R&D Officer | - |
Training of Shane Olwill
| University of Ulster | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FUSION ANTIBODIES PLC | Health Services |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Shane Olwill
